Cataract Clinical Trial
— SISALensOfficial title:
Evaluation of the Rotational Stability of the Monofocal SISA Implant Following Cataract Surgery
Verified date | November 2017 |
Source | Centre Hospitalier Universitaire de Nimes |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
A good efficacy as well as good rotary stability is expected with the ocular implant.
Status | Completed |
Enrollment | 20 |
Est. completion date | July 11, 2018 |
Est. primary completion date | July 11, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - The patient must have given their free and informed consent and signed the consent form - The patient must be a member or beneficiary of a health insurance plan - The patient must be available for 6 months follow-up - The patient it aged at least 18 years - Patient requires surgery for cataracts with removal of the opacified natural lens and replacement with the SISA implant, according to standard procedure - The surgery is elective - The patient has clear and non-pathological corneas - The patient needs an implant strength (LIO) between +10D and +30D - Corneal astigmatism less than or equal to 1.50D in the eye to be operated (or cataract eye Exclusion Criteria: - The subject is participating in an interventional study, or is in a period of exclusion determined by a previous study - The patient is under safeguard of justice or state guardianship - The subject refuses to sign the consent - It is impossible to give the subject informed information - The patient is pregnant or breastfeeding - The patient has other ocular comorbidities with poor visual acuity prognosis postoperatively - Previous ocular trauma or surgery - Dilation of the pupil <7mm with mydriatic drugs - Implantation with a rhexis that does not cover the optic of the implant by more than 1 cadranel |
Country | Name | City | State |
---|---|---|---|
France | CHU Nimes | Nîmes |
Lead Sponsor | Collaborator |
---|---|
Centre Hospitalier Universitaire de Nimes |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Rotational stability of SISA monofocal implant following cataracts surgery | rotation in degrees measured by Labview software | 4 Months | |
Secondary | Rotational stability of SISA monofocal implant following cataracts surgery | rotation in degrees measured by Labview software | Day 0 | |
Secondary | Rotational stability of SISA monofocal implant following cataracts surgery | rotation in degrees measured by Labview software | Day 7 | |
Secondary | Rotational stability of SISA monofocal implant following cataracts surgery | rotation in degrees measured by Labview software | 1 Month | |
Secondary | Centering of SISA monofocal implant | Distance in mm between centers of the coreal and optic ellipses | Day 0 | |
Secondary | Centering of SISA monofocal implant | Distance in mm between centers of the coreal and optic ellipses | Day 7 | |
Secondary | Centering of SISA monofocal implant | Distance in mm between centers of the coreal and optic ellipses | Month 1 | |
Secondary | Centering of SISA monofocal implant | Distance in mm between centers of the coreal and optic ellipses | Month 4 | |
Secondary | Refractive precision | Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters | Day 7 | |
Secondary | Refractive precision | Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters; | Month 1 | |
Secondary | Refractive precision | Early Treatment Diabetic Retinopathy Study scale; chart 1 at 4 meters; diopters | Month 4 | |
Secondary | Visual acuity with and without correction | Early Treatment Diabetic Retinopathy Study scale, logMAR | Day 7 | |
Secondary | Visual acuity with and without correction | Early Treatment Diabetic Retinopathy Study scale, logMAR | Month 1 | |
Secondary | Visual acuity with and without correction | Early Treatment Diabetic Retinopathy Study scale, logMAR | Month 4 | |
Secondary | Perioperative complications | Yes/no | Day 0 | |
Secondary | Postoperative complications | Yes/no | Day 7 | |
Secondary | Occurrence of undesirable events, | Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, | Day 0 | |
Secondary | Occurrence of undesirable events, | Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, | Day 7 | |
Secondary | Occurrence of undesirable events, | Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, | Month 1 | |
Secondary | Occurrence of undesirable events, | Presence/absence of each event, including, but not limited to: inflammation, retinal detachment, macular edema, corneal endothelial lesion,corneal edema, implant gets decentred or tilted, | Month 7 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04685538 -
Chloroprocaine 3% Gel Eye Drop as Topical Anestheticsin Phacoemulsification.
|
Phase 3 | |
Recruiting |
NCT06060041 -
IC-8 Apthera IOL New Enrollment Post Approval Study
|
||
Recruiting |
NCT05518539 -
Evaluation of Quality of Vision and Visual Outcomes With Bilateral Implantation of the Clareon PanOptix Intraocular Lens
|
||
Recruiting |
NCT05271942 -
Tilt and Tumble vs Divide and Conquer - a Unique Comparison of the Two Cataract Surgery Methods
|
N/A | |
Active, not recruiting |
NCT04778501 -
PMCF Study on Monofocal Toric IOL (PODEYE TORIC) in Asia
|
N/A | |
Completed |
NCT05062564 -
Efficacy of LipiFlow in Patients Affected by Meibomian Gland Dysfunction in Reducing Post-cataract Surgery Dry Eye
|
N/A | |
Completed |
NCT03751033 -
Influence of DisCoVisc Ophthalmic Viscosurgical Device (OVD) on Intraoperative Aberrometry Readings
|
N/A | |
Completed |
NCT02529488 -
Investigation of AcrySof® IQ PanOptix™ Presbyopia-Correcting Intraocular Lens (IOL) Model TFNT00
|
N/A | |
Completed |
NCT04539548 -
A Study Assessing the Safety and Efficacy of Dextenza® for the Treatment of Ocular Pain and Inflammation Following Surgery for Pediatric Cataract
|
Phase 3 | |
Completed |
NCT03740659 -
Evaluation Of Aqueous Humor Of Levofloxacin-Dexamethasone Eye Drops And Of Its Components In Patients Undergoing Cataract Surgery
|
Phase 2 | |
Completed |
NCT03494257 -
Effect of Fixed Brinzolamide-brimonidine Combination on Intraocular Pressure After Phacoemulsification
|
N/A | |
Completed |
NCT05119127 -
Rotational Stability of Acrysof IQ Vivity Extended Vision Toric IOL and Refractive Visual Outcome.
|
N/A | |
Active, not recruiting |
NCT04271709 -
Manhattan Vision Screening and Follow-Up Study (NYC-SIGHT)
|
N/A | |
Recruiting |
NCT03713268 -
Intraoperative OCT Guidance of Intraocular Surgery II
|
||
Completed |
NCT03739528 -
Levo-Dexa vs. Tobra+Dexa for Prevention and Treatment of Inflammation and Prevention of Infection in Cataract Surgery
|
Phase 3 | |
Completed |
NCT02888210 -
A Study Assessing Safety and Efficacy of MD-15 Intraocular Lens in Patients With Aphakic Eye After Cataract Surgery
|
Phase 3 | |
Completed |
NCT04332640 -
Clinical Evaluation of the Next Generation Phaco System
|
N/A | |
Recruiting |
NCT03638726 -
Subconjunctival Atropine and Intracameral Epinephrine for Pupil Dilation in Phacoemulsification
|
Phase 4 | |
Completed |
NCT03050697 -
Evaluation of the Safety and Performance of the HARMONI® Toric Lens
|
N/A | |
Terminated |
NCT03145116 -
Clinical Safety and Efficacy of CT ASPHINA 509 Lenses
|
N/A |